Dr. Baird is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Duarte Road
Duarte, CA 91010Phone+1 626-218-2405Fax+1 626-389-3058
Summary
- I am an assistant professor in the Division of Lymphoma, Department of Hematology and HCT at City of Hope National Medical Center in Duarte, CA. I am boarded in Internal Medicine, Hematology, and Medical Oncology. I have a background in clinical and translational research, and specialize in CAR-T therapies for hematologic malignancies. My particular research interests lie in novel drug development and translational pathobiology for leukemia and lymphoma.
Clinical Expertise
- Hematologic oncology, Myeloproliferative disease, Anemia
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2020 - 2021- Stanford Health CarePost-Doctoral Fellowship, 2019 - 2020
- Stanford Health CareFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2016- University of Pennsylvania Health SystemInternship, Internal Medicine, 2013 - 2014
University of Arkansas For Medical Sciences College of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2016 - 2026
PA State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Richard V. Ebert Award Dept. of Internal Medicine, UAMS, 2013
- Graduated with Honors in Research UAMS College of Medicine, 2013
- Clinical Research Training Program (CRTP) Fellow OCRTME, National Institutes of Health (NIH), 2012
Clinical Trials
- Natural History of Sickle Cell Disease Start of enrollment: 2004 Apr 29
- Carbon Monoxide Levels and Sickle Cell Disease Severity Start of enrollment: 2012 Jan 26
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies Start of enrollment: 2017 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA Primer on Chimeric Antigen Receptor T-cell Therapy-related Toxicities for the Intensivist.Shin Yeu Ong, John H Baird
Journal of Intensive Care Medicine. 2024-10-01 - Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells.Ryan Urak, Saghar Pahlavanneshan, Brenna Gittins, Ryotaro Nakamura, John A Zaia
Haematologica. 2024-09-01 - 4 citationsCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.Matthew J Frank, John H Baird, Anne Marijn Kramer, Hrishikesh K Srinagesh, Shabnum Patel
Lancet. 2024-07-27
Books/Book Chapters
Press Mentions
Scotland's Most Promising Scientists Awarded £12 MillionOctober 15th, 2020
Our Great Talent for Invention Will Lead Us Out of Darkness, Says LEO McKINSTRYApril 4th, 2020
Committees
- Ad Hoc Reviewer, British Journal of Haematology Editorial Board 2015 - Present
- Curriculum Author, Hospital of the Univ. of Pennsylvania Dept. of Medicine Nightfloat Curriculum Committee 2014 - 2016
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
